Methicillin-resistant Staphylococcus aureus (MRSA) carriage in a dermatology unit

CLINICAL SCIENCE

Methicillin-resistant Staphylococcus aureus (MRSA) carriage in a dermatology unit

Renata L. Pacheco^I; Renata D. Lobo^II; Maura S. Oliveira^II; Elthon F. Farina^I; Cleide R. Santos^II; Silvia F. Costa^I; Maria Clara Padoveze^III; Cilmara P. Garcia^II; Priscila A. Trindade^I; Ligia M. Quité rio^IV; Evandro A. Rivitti^IV; Elsa M. Mamizuka^V; Anna S. Levin^I,II

^IHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Department of Infectious Diseases and LIM-54, São Paulo/SP, Brazil

^IIHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Department of Infection Control of São Paulo, São Paulo/SP, Brazil

^IIIUniversidade de São Paulo, Nursing School, Department of Collective Health, São Paulo/SP, Brazil

^IVHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Department and Division of Dermatology, São Paulo/SP, Brazil

^VUniversidade de São Paulo, Department of Clinical Analyses, Faculdade de Ciências Farmacêuticas, São Paulo/SP Brazil

ABSTRACT

OBJECTIVE: The aim of this study was to characterize Staphylococcus aureus (MRSA) carriage in a dermatology unit.

METHODS: This was a prospective and descriptive study. Over the course of 26 weeks, surveillance cultures were collected weekly from the anterior nares and skin of all patients hospitalized in a 20-bed dermatology unit of a tertiary-care hospital. Samples from healthcare workers (HCWS) were cultured at the beginning and end of the study. Colonized patients were put under contact precautions, and basic infection control measures were enforced. Staphylococcus aureus colonization pressure was determined monthly. Colonized and non-colonized patients were compared, and isolates were evaluated for antimicrobial susceptibility, SCCmec type, virulence factors, and type.

RESULTS: Of the 142 patients evaluated, 64 (45%) were colonized by MRSA (39% hospital acquired; 25% community acquired; 36% indeterminate). Despite isolation precautions, hospital-acquired Staphylococcus aureus occurred in addition to the continuous entry of Staphylococcus aureus from the community. Colonization pressure increased from 13% to 59%, and pemphigus and other bullous diseases were associated with MRSA colonization. Eleven out of 71 HCWs (15%) were Staphylococcus aureus carriers, although only one worker carried a persistent clone. Of the hospital-acquired MRSA cases, 14/28 (50%) were SCCmec type IV (3 PFGE types), 13 were SCCmec type III (46%), and one had an indeterminate type. These types were also present among the community-acquired Staphylococcus aureus isolates. SSCmec type IV isolates were shown to be more susceptible than type III isolates. There were two cases of bloodstream infection, and the pvl and tst virulence genes were absent from all isolates.

CONCLUSIONS: Dermatology patients were colonized by community- and hospital-acquired Staphylococcus aureus. Half of the nosocomial Staphylococcus aureus isolates were SCCmec type IV. Despite the identification of colonized patients and the subsequent contact precautions and room placement, Staphylococcus aureus colonization continued to occur, and colonization pressure increased. Pemphigus and other bullous diseases were associated with Staphylococcus aureus.

Keywords: Transmission; Surveillance culture; Molecular typing; MRSA; Hospital infection.

INTRODUCTION

Staphylococcus aureus is a versatile pathogen capable of causing a wide variety of infections.¹The prevalence of nosocomial and community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections has increased in recent years.²Methicil lin resistance of Staphylococcus aureus is mediated by a penicillin-binding protein (PBP2A) that has a low affinity for b-lactam antibiotics and is encoded by the mecA gene.^3,4 This gene is carried on a mobile genetic element designated as Staphylococcal Cassette Chromo some mec (SCCmec), which is integrated into the chromo some. Currently, 11 types of SCC mec have been reported.^5-7 In healthcare settings, patients who are colonized by or infected with MRSA serve as a reservoir and a source for the spread of this microorganism, which occurs mainly through transiently colonized healthcare workers (HCWs).^8,9

Carriage of S. aureus is considered a risk factor for the development of infections, as infections are usually preceded by a period of colonization.¹⁰

The objective of this study was to characterize MRSA carriage in a hospital dermatology unit.

METHODS

Hospital das Clínicas is a tertiary-care teaching hospital that is affiliated with the University of São Paulo, Brazil. It has approximately 2,000 beds and is divided into 6 buildings. The dermatology unit has 20 beds, which are distributed across 10 rooms of one, two, or four beds each. This unit is used for the hospitalization of patients with severe dermatologic conditions. On average, there are 30 admissions per month and 4,500 patient-days each year.

Surveillance cultures of patients

Over a period of 26 weeks that began on May 31, 2005, weekly surveillance cultures for MRSA were obtained from all of the patients admitted to the unit. These samples were collected from the anterior nares and skin lesions. Patients who were positive for MRSA were not followed for further surveillance cultures. Patients who were negative for MRSA were cultured weekly until their discharge from the unit.

Due to the high proportion of patients who tested positive on the first surveillance culture, patients were cultured upon admission and then weekly from the 13th week of the study onward.

The swabs from the anterior nares were collected by introducing a swab into the nasal vestibulum and then rubbing with light pressure. The swabs were transported in sterile tubes containing culture medium and were sent immediately to the laboratory for further processing and analysis. The swabs from skin lesions were collected by gently scraping or rolling the swab across the lesion.

Definitions

Nosocomial acquisition of MRSA was defined as a positive culture in a patient who had been in the hospital for more than 48 hours and whose previous surveillance cultures at both sites had been negative (nares and skin).

For patients who were positive within the first 48 hours of hospitalization, MRSA was considered to have been present at the time of hospital admission. All other colonizations were considered indeterminate as to where MRSA acquisition occurred.

The following patient data were registered upon admission to the study: age, sex, date of admission to the hospital, underlying diseases, hospitalization within the previous 12 months, and use of antimicrobial drugs. The patients were followed until their discharge from the unit. We evaluated the colonization of the patients by dividing the study into six periods.

Control measures

All patients positive for MRSA were placed in separate rooms or were placed in a cohort with other MRSA carriers and put under contact precautions until hospital discharge or death. Hand hygiene was enforced by requiring the use of alcohol gel. There were two educational meetings with members of the staff in which the control measures and their objectives were discussed. Posters were spread throughout the unit to report the weekly number of patients colonized by MRSA. Patients also received information regarding the contact precautions and their importance.

Surveillance cultures of healthcare workers (HCWs)

The anterior nares of the healthcare workers were cultured on two occasions: at the beginning and at the end of the study. HCWs who tested positive were not treated.

Ethics

The study protocol followed the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Commission of the Hospital das Clínicas (approval number: 1072/04).

Analysis of data

Continuous variables are herein presented as the means ± standard deviation or median and range. Frequencies were calculated for the categorical variables. MRSA-colonized patients were compared to non-colonized patients using the x ²test for categorical variables and the Mann Whitney test for continuous variables. The data were analyzed using Epi Info 6.04 software (CDC, Atlanta, USA). A p-value of 0.05 was considered statistically significant.

For each period, we determined the total number of patient-days and the number of MRSA patient-days (by summing the days that each MRSA-colonized patient remained in the unit after the day that MRSA colonization was first identified). Colonization pressure was also determined for each period by dividing the number of MRSA patient-days by the total number of patient-days (expressed as a percentage).

Microbiological methods

Detection of MRSA. Samples were plated onto mannitol salt agar (MSA) and inoculated into brain heart infusion (BHI) broth. Mannitol-fermenting colonies were subcultured onto 5% sheep blood agar plates. If the initial MSA culture was negative, a subculture from the BHI broth was carried out on MSA plates to increase the sensitivity of detection. S. aureus was identified by Gram staining and DNAse and catalase tests. Methicillin resistance was determined using Mueller Hinton agar supplemented with 4% NaCl and 6 mg/mL oxacillin according to guidelines of the Clinical Laboratory Standards Institute (CLSI). ¹¹If there was growth of at least one colony-forming unit, the culture was considered positive. S. aureus ATCC 29213 and NCTC 10442 were used as controls.

The phenotypic identification was confirmed by polymerase chain reaction (PCR), amplifying 117 bp and 214 bp fragments from the coagulase and mecA genes, respectively, using the NCL-SA-PS kit (Novo Castra, United Kingdom), as previously described by Kearns et al.¹²

Susceptibility testing. Minimal inhibitory concentrations (MICs) were determined using the broth microdilution me thod and were interpreted according to CLSI guidelines ^11,13for oxacillin, penicillin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, gentamicin, rifampicin, sulfamethoxazole/trimethoprim, tetracycline and vancomycin.

Molecular typing. Molecular typing was performed by digesting whole-cell DNA with the SmaI macrorestriction enzyme (Fermentas Life Sciences, Canada) and then determining the fragment-size patterns obtained with pulsed-field gel electrophoresis (PFGE) using a CHEF DR II apparatus (Bio-Rad Laboratories, USA). ¹⁴The patterns were analyzed as recommended by Tenover et al. ¹⁵Types were de fined as isolates that differed by at least seven fragmen ts and were identified using letters. Subtypes of a given clonal type were defined as those isolates that differed by fewer than seven fragments and were identified using numbers.

Multilocus sequence typing was performed for 10 isolates accordin g to methods described elsewhere. ¹⁶This sequence typing was performed for one isolate of each PFGE type (seven isolates), one isolate for which the SCCmec type could not be determined and two isolates in which mec A could not be detected.

SCC mec typing. The determination of the SCCmec type was performed using the multiplex PCR method, as describe d by Oliveira & Lencastre.¹⁷DNA was extracted using a commercial kit (Genomic Prep Cells and Tissue DNA Isolation, Amersham Pharmacia, Biotech, Germany). PCR amplifications were performed using a GeneAmp PCR System 2400 thermocycler (Perkin-Elmer, Waltham, MA, USA). The MRSA strains NTCT 10442, N315, 85/2082 and JSCS 1968, which belong to SCCmec types I, II, III, and IV, respectively, were used as positive controls.

Detection of genes for virulence factors. One isolate from each PFGE subtype was evaluated for the Panton Valentine leukocidin (pvl), LukE-LukD leukocidin (lukElukD) and toxic shock syndrome toxin-1 (tst) virulence genes by PCR using primers described elsewhere.¹⁸Briefly, samples were denatured for 5 minutes at 94˚C; subjected to 3 0 c ycles of denaturation at 95˚C for 30 seconds, annealin g at 55˚C for 1 minute, and extension at 72˚C for 2 min; and then subjected to a final extension at 72˚C for 5 minutes. The MR108 (positive for pvl) and N315 (positive for lukE-lukD and tst) isolates were used as controls.

RESULTS

During the study period, 153 patients were admitted to the dermatology unit. Of these, 11 were lost to follow-up, and 142 were evaluated until discharge and included in the analysis.

Of the 142 patients, 64 (45%) were colonized by MRSA. There were 26 patients who were positive only from the culture of the anterior nares (one patient harbored two isolates), 11 who were positive only from skin culture and 27 who had tested positive from both sites (two patients each harbored three isolates). Thus, 94 MRSA isolates from 64 patients were microbiologically evaluated.

Among the 64 patients (45%) who were colonized by MRSA, 25 (39%) had hospital-acquired infections, 16 (25%) were colonized at the time of admission and 23 patients (36%) had an indeterminate site of acquisition. The distribut ions over time of patients who were colonized at the time of admission and of those who acquired MRSA in the hospital are presented in Figure 1. Despite the control mea sure s, the nosocomial acquisition of MRSA occurred during the entire study period. In addition, during the entire study period, there was a continuous entry of patients who were MRSA positive at the time of admission, and the colonization pressure also increased over the six-month study period (Figure 1).

The characteristics of the MRSA-colonized and non colonized patient populations are presented in Table 1. Bullous diseases, such as pemphigus and others, were significantly more frequent among colonized patients.

The SCCmec types and molecular types of the 94 isolates were determined. When a patient harbored more than one isolate of the same SCCmec type and PFGE type, only one isolate for that patient was included in the final analysis. Therefore, 67 isolates from 64 patients were analyzed. There were seven molecular PFGE types (A to G) that were divided into 30 subtypes. The distribution of the patient isolates according to the origin of acquisition, SCC mec type and molecular type is presented in Table 2. The results of the MLST for isolates of each PFGE type (A to G) are presented in Table 3.

The SCCmec type IV isolates belonged to four different PFGE molecular types (A-D) and four different sequence types (ST5, ST8, ST97 and ST1176). However, the PFGE type and ST did not correlate completely, as ST8 belonged to two different PFGE types (B and D), and there were 2 ST (ST97 and ST5) among the isolates of PFGE type C.

Of the SCCmec type III isolates, there were 3 PFGE molecular types (E-G), all of which belonged to ST239, as does the multiresistant Brazilian Endemic Clone (BEC).

Of the isolates obtained at the time of patient admission, most were SCCmec type IV, but there were also four isolates that were similar to the BEC.

The hospital-acquired isolates were evenly distributed among SCCmec types IV and III.

Among the 30 isolates tested (all carried SCCmec type IV), the pvl and tst virulence factors were absent from all of them, and the lukD-lukE gene was present in all of them.

During the study period, there were two cases of bloodstream infections. These were caused by MRSA of SCCmec type IV and PFGE type A. These patients had been colonized by the same subtypes at earlier time points (25 and 40 days prior).

Thirty-seven healthcare workers (HCWs) were cultured at the beginning of the study, and 34 were cultured at the end of the study. Of these, five (14%) were positive on the first occasion , and six (18%) were positive on the second. The distribut ion of the isolates from healthcare workers accord ing to SCCmec type and molecular type is presented in Table 4. Fifteen HCWs were cultured on both occasions, and three w ere positive on both occasions, bu t only one healthcare worker (belonging to the housekeeping staff) presented the same subtype twice (C3). However, none of the patients presented the C3 subtype.

The antimicrobial susceptibilities of the isolates that colonized 60 patients and 11 healthcare workers are shown in Table 5.

DISCUSSION

Colonization with MRSA was prevalent among patients hospitalized for dermatological diseases (45%), and this colonization was due to both hospital acquisition and colonization prior to admission.

This study began by examining routine surveillance cultures to determine the extent of the problem and to identify patients who should be placed under contact precautions, such as placement in a private room or in a patient cohort. Through the enforcement of these measures, we expected to halt the nosocomial transmission of MRSA. Community-acquired MRSA (CA-MRSA) has been rarely described in Brazil and has been shown to occur mainly in the southern region of the country^19,20near the border with Uruguay, which is a country in which CA-MRSA is a significa nt problem. In addition, in a previous study of MRSA isolates obtained from bloodstream infections,²¹ there were six cases of hospital-acquired MRSA bacteremia the dermatology unit. Thus, we expected most of the cases of MRSA colonization to be hospital acquired. However, in our dermatology unit, we observed that approximately half of the colonization cases were hospital-acquired and that a significa nt proportion of patients were positive for MRSA at the time of admission. Our results suggest that many patients are colonized by community-acquired MRSA or are colonize d at other healthcare facilities and may be a source of MRS A transmission to other patients in the hospital. There was a significantly higher proportion of patients with pemphigus and other bullous diseases among MRSA carriers, which suggested that disseminated bullous disease is a risk factor for MRSA colonization.

During the entire study period, nosocomial transmission of MRSA occurred as well as admission of colonized patients. This likely generated or increased colonization pressure and made control more difficult despite the efforts directed to prevent nosocomial MRSA transmission. Over the six-month study period, the frequency of nosocomialacquired cases tended to decrease, but the colonization pressure increased from 13% to 59%. We attributed this decrease in the nosocomial acquisition of MRSA to the extensive efforts of the staff, which included improving the isolation conditions and the infection control measures. Our original goal was the complete eradication of nosocomial transmis sion, but this goal was not achieved. The coloniza tion pressure was first evaluated for vancomycin-resistant enterococci.²² This type of resistance has been studied in MRSA and has been shown to play a role as a risk factor for nosocomial transmission.²³In one study, a colonization pressure above 30% led to a 5-fold increase in the risk of MRSA colonization.²⁴

Due to the large number of patients who are colonized at the time of admission, the use of routine surveillance cultures and the placement of colonized patients into cohorts may not affect the rates of colonization unless all patients are immediately placed under contact precautions even before the surveillance cultures are analyzed. Furthermore, the success of MRSA control that is based mainly on the identification of carriers through the analysis of surveillance cultures depends on the sensitivity of these cultures, which may not be sufficiently high to detect all colonized patients. Some authors have reported that the lack of throat culturing may lead to an underestimation of the percentage of MRSA carriers by as much as 8 to 18%.^25,26

The clinical impact and the relevance of routine patient culturing may be contested because, despite a high proportion of colonized patients, there were only two cases of bloodstream infection in our six-month study period. Routine culturing and the use of patient cohorts and private rooms for positive patients are expensive and laborintensive measures. In our hospital, most rooms are meant to hold two or four patients, and there are very few private rooms. During patient isolation, the rooms are not used at full capacity, which is a problem because there is a nationwide shortage of hospital beds. In addition, although the carriage of S. aureus is considered a risk factor for the development of infection,¹⁰one prospective study found that nasal colonization with MRSA was a poor predictor of the subsequent occurrence of MRSA respiratory tract or bloodstream infection.²⁷

This study also addressed the role of HCWs in the transmission of MRSA. Among HCWs, MRSA was observed in 15% of the cultures. Only three HCWs were positive on both occasions, but two HCWs harbored different molecular types of MRSA at each culture, suggesting transient carriage. Interestingly, half of the HCWs who were positive for MRSA harbored isolates of subtypes that were not present among the patients. This result suggests that a large proportion of the HCW colonizations were acquired outside of the hospital, either in the community or at other institutions.

MRSA with SCCmec type III was multidrug resistant and belonged to the Brazilian Endemic Clone (BEC). Molecular typing by pulsed-field gel electrophoresis (PFGE) revealed three different types and one predominant type (79%). Within this predominant type, there were nine different subtypes. The BEC has been endemic in Brazil for more than a decad e.²⁸During this time, it is likely that changes occurred that made Tenover’s criteria¹⁷ inadequate to interpret its clonality. In this situation, multilocus sequence typing (MLST) is more useful because it evaluates seven housekeeping genes that are more stable over time.²⁹BEC presents as sequence type ST-239,²⁸and all of the SCCmec type III isolates tested in our study also belonged to this ST.

The presence of MRSA with SCCmec type IV at our hospital is a more recent phenomenon than the existence of the BEC. Therefore, the PFGE typing reflected clonality that was similar although n ot identical to the MLST.²¹ Furthermore, we expected that the SCCmec type IV would be mainly community acquired. However, similar to other geographic areas,³⁰it seems as though this type has crossed hospital borders and circulates not only in the community but also in the hospital environment.

As observed in other studies conducted at our hospital,^21,31SCCmec type IV MRSA isolates from dermatologic patients did not express the Panton-Valentine leukocidin (PVL) virulence factor. The t st gene was also absent from all of the i solates. This finding is interesting because PVL producing clones have been associated with skin and soft tissue infections^32,33 and because TSST-1 is the cause of skin lesions. On the other hand, in a hospital environment, where patients are severely ill and have many diseases, a virulent strain of S. aureus would probably not be successful because it would cause severe infection and high mortality, as it does in the community.

Our study has limitations. First, it was our original intention to use the CDC definitions, but the necessary information was not available for a large proportion of the included patients. Because of this lack of information, we had to introduce the ‘‘indeterminate’’ category. There was a large proportion of patients for which the origin of colonization was deemed indeterminate, which was in part due to the fact that surveillance culturing immediately upon admission was only initiated halfway into the study. In addition, we did not observe SCCmec types other than types I to IV, and there were a few isolates for which we could not determine the type. Finally, it was not possible to perform MLST analyses on each of the PFGE subtypes.

In summary, almost half of the dermatology patients in this study were colonized by MRSA at the time of hospital admission or acquired MRSA while in the hospital. Half of the nosocomial MRSA cases were SCCmec type IV. Nosocomial MRSA colonization continued throughout the study period despite the identification of colonized patients, the use of contact precautions and patient cohorting or the placement of patients in private rooms based on their surveillance cultures. Colonization pressure continuously increased during the study period, which may partly explain the difficulty in controlling the spread of MRSA. Pemphigus and other bullous diseases were significantly associated with MRSA colonization. The healthcare workers were predominantly colonized by SCC mec type IV MRSA, and this colonization was found to be transient and predominantly community acquired.

ACKNOWLEDGMENTS

This study was funded by grants from the Fundação de Amparo a' Pesquisa do Estado de São Paulo (FAPESP)-06/03003-7; 05/5754-0 and 06/ 00569-0.

We thank Robson E. Soares for his suggestions in the laboratory and with the manuscript.

AUTHOR CONTRIBUTIONS

Pacheco RL was responsible for the collection of patient data and clinical specimens, laboratory procedures and analysis of data. Lobo RD was responsible for the collection of data and specimens, implementation of control measures and contributed to the writing of the manuscript. Oliveira MS was responsible for the collection of data and specimens, implementation of control measures and contributed to the writing of the manuscript. Farina EF was responsible for the laboratory procedures and analysis of data. Santos CR was responsible for the collection of data and specimens and implementation of control measures. Costa SF supervised the laboratory work. Padoveze MC and Garcia CP contributed to the writing of the manuscript. Trindade PA was responsible for the laboratory procedures. Quitério LM and Rivitti EA were responsible for the organization of the unit and implementation of control measures. Mamizuka EM was responsible for the laboratory procedures. Levin AS was responsible for the general supervision and the writing of the manuscript.

REFERENCES

1. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:S350-9, doi: 10.1086/533591.

2. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46:S344-9, doi: 10.1086/ 533590.

3. Ito T, Hiramatsu K. Acquisition of methicilin resistance and progression of multiantibiotic resistance in methicilin-resistant Staphylococcus aureus. Yonsei Med J. 1998;39:526-33.

4. Hiramatsu K, Ito T, Hanaki H. Mechanisms of methicillin and vancomyci n in Staphylococcus aureus. Clin Infect Dis. 1999;5:221-42.

5. Shore AC, Deasy EC, Slickers P, Brennan G, O’Connell B, Monecke S, et al. Detection of Staphylococcal Cassette Chromosome mec Type XI Carrying Highly Divergent mecA, mecI, mecR1, blaZ, and ccr Genes in Human Clinical Isolates of Clonal Complex 130 Methicillin-Resistant Staphyloco ccus aureus. Antimicrob Agents Chemother. 2011;55:3765-73, doi: 10.1128/AAC.00187-11.

6. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004;48:2637-51, doi: 10.1128/AAC.48.7.2637-2651.2004.

7. Oliveira DC, Milheirico C, Lencastre H. Redefining a structural variant of staphyloco ccal cassette chromosome mec, SCCmec type VI. Antimicrob Agents Chemother. 2006;50:3457-9, doi: 10.1128/AAC.00629-06.

8. Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care. 2006;10:R25, doi: 10.1186/cc3982.

9. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008;8:289-301, doi: 10.1016/S14733099(08)70097-5.

10. Kluitmans J, Wertheim HF. Nasal carriage of Staphylococcus aureus: and prevention of nosocomial infections. Infection. 2005; 33:3-8, doi: 10.1007/ s15010-005-4012-9.

11. Clinical and Laboratory Standards Institute, Performance standard for antimicrobial susceptibility testing. Document M100– S17. Wayne, Pennsylvania: CLSI, 2007.

12. Kearns AM, Seiders PR, Wheeler J, Freeman R, Steward M. Rapid detection of methicillin-resistant staphylococci by multiplex PCR. J Hosp Infect. 1999;43:33-7, doi: 10.1053/jhin.1999.0631.

13. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. In Approved standard M7-A5 5th edition. NCCLS. Wayne, Pa, 2002.

14. Bannerman TL, Hancock GA, Tenover FC, Miller JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol. 1995;33:551-5.

15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.

16. Enright MC, Day NP, Davies CE Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methi cillin-susceptile clones of Stapylococcus aureus. J Clin Microbiol. 2000;38:100 8-15.

17. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identificati on of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2002;46:2155-61, doi: 10.1128/AAC.46.7.2155-2161.2002.

18. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70:631-41, doi: 10.1128/IAI.70.2.631-641.2002.

19. Ribeiro A, Coronado AZ, Silva-Carvalho MC, Ferreira-Carvalho BT, Dias C, Rozenbaum R, et al. Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clo nes in Rio de Janeiro and Porto Alegre cities causing both community-and hospital-associated diseases. Diagn Microbiol Infect Dis. 2007; 59:339-45, doi: 10.1016/j.diagmicrobio.2007.05.007.

20. Ribeiro A Dias C, Silva-Carvalho MC, Berquó L, Ferreira FA, Santos RN, F erreira-Carvalho BT, et al. First report of infection with community a cquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol. 2005;43:1985-8, doi: 10.1128/JCM.43.4.1985-1988.2005.

21. T rindade PDA, Pacheco RL, Costa SF, Rossi F, Barone AA, Mamizuka E M, et al. Prevalence of SCCmec Type IV in Nosocomial Bloodstream Isolate of Methicillin-Resistant Staphylococcus aureus Clone. J Clin Microbiol. 2005;43:3435-7, doi: 10.1128/JCM.43.7.3435-3437.2005.

22. B onten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, N athan C, et al. The role of ‘‘colonization pressure’’ in the spread of vancomyci n-Resistant enterococci-an important infection control vari a ble. Arch Intern Med. 1998;158:1127-32, doi: 10.1001/archinte.158.10. 1127.

23. Williams VR, Callery S, Vearncombe M, Simor AE. The role of colonizatio n pressure in nosocomial transmission of methicillinresistant Staphyloco ccus aureus. Am J Infect Control. 2009;37:106-110, doi: 10. 1016/j.ajic. 2008.05.007.

24. Merrer J, Santoli F, Appéré de Vecchi C, Tran B, De Jonghe B, Outin H. ‘‘Colonizat ion pressure’’ and risk of acquisition of methicillin-resistant Staphyloco ccus aureus in a medical intensive care unit. Infect Control H osp Epidemiol. 2000;21:718-23, doi: 10.1086/501721.

25. Mertz D, Frei R, Jaussi B, Tietz A, Stebler C, Fluckiger U, et al. Throat Swabs Are Necessary to Reliably Detect Carriers of Staphylococcus aureus. Clin Infect Dis. 2007;45:475–7, doi: 10.1086/520016.

26. Nilsson P, Ripa T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol. 2006;44:3334–9, doi: 10.1128/JCM.00880-06.

27. Sarikonda KV, Micek ST, Doherty JA, Reichley RM, Warren D, Kollef MH. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor pred ictor of intensive care unit-acquired methicillin-resistant Staphyloco ccus aureus infections requiring antibiotic treatment. Crit Care Med. 2010;38:1991-5.

28. Vivoni AM, Diep BA, de Gouveia Magalhães AC, Santos KR, Riley LW, Sensabaug h GF, et al. Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. J Clin Microbiol. 2006;44:1686-91, doi: 10.1128/JCM. 44.5.1686-1 691.2006.

29. Faria NA, Carrico JA, Oliveira DC, Ramirez M, de Lencastre H. Analysis of typing methods for epidemiological surveillance of both methicillin resistant and methicillin-susceptible Staphylococcus aureus strains. J Clin Microbiol. 2008;46:136-44, doi: 10.1128/JCM.01684-07.

30. Schuenck RP, Nouér SA, Winter Cde O, Cavalcante FS, Scotti TD, Ferreira AL, et al. Polyclonal presence of non-multiresistant methicillin resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associ ated infections in a hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis. 2009;64:434-41, doi: 10.1016/j.diagmicrobio.2009.04.007.

31. V idal PM, Trindade PA, Garcia TO, Pacheco RL, Costa SF, Reinert C, et al. Differences between ‘‘classical’’ risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for n osocomial bloodstream infections caused by multiple clones of the staphyloco ccal cassette chromosome mec type IV MRSA strain. Infect Control Hosp Epidemiol. 2009;30:139-45, doi: 10.1086/593954.

32. B oyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphyloco ccus aureus: the role of Panton-Valentine leukocidin. Lab I nvest. 2007;87:3-9, doi: 10.1038/labinvest.3700501.

33. Jahamy H, Ganga R, Al Raiy B, Shemes S, Nagappan V, Sharma M, et al. Staphylococcus aureus skin/soft-tissue infections: the impact of SCC type and Panton-Valentine leukocidin. Scand J Infect Dis. 2008;40:601-6, doi: 10.1080/00365540701877312.

Received for publication on July 3, 2011; First review completed on July 15, 2011; Accepted for publication on August 29, 2011

No potential conflict of interest was reported.

E-mail: [e-mail]

Tel.: [phone]

Publication Dates

• Publication in this collection
  20 Dec 2011
• Date of issue
  2011